Comparison between subcutaneous and conjunctival route of vaccination with Rev. 1 strain against Brucella melitensis infection in ewes
- PMID: 7185320
Comparison between subcutaneous and conjunctival route of vaccination with Rev. 1 strain against Brucella melitensis infection in ewes
Abstract
In areas where the prevalence of Brucella melitensis infection in sheep is high, control of the disease cannot be led without the help of vaccination. The use of Brucella melitensis strain Rev. 1 vaccine affords a very good protection. The drawback is that this vaccine, giving rise to long-lasting antibody titers, may disturb serological screening when a return is made to a test and slaughter policy, after several years of vaccination. There is a great need for another mode of vaccination which would avoid this disadvantage. In this experiment, the potency of a vaccination by conjunctival route with 1.4 X 10(8) Rev. 1, plus a recall of 2.9 X 10(8) six months later, was compared with that of the normal subcutaneous vaccination with 1.4 or 2.7 X 10(9) Rev. 1. The vaccination by conjunctival route afforded a somewhat better protection than the subcutaneous one, and with a shorter serological response. It may be possible that a single conjunctival vaccination, avoiding the difficulties of vaccinating twice in ovine flocks and giving few antibodies, could also afford a good protection. Research in progress should include investigation of this point.
Similar articles
-
Vaccination of ewes by a single conjunctival administration of Brucella melitensis Rev. 1 vaccine.Ann Rech Vet. 1985;16(4):351-6. Ann Rech Vet. 1985. PMID: 4091489
-
Residual virulence and immunogenicity of CGV26 and CGV2631 B. melitensis Rev. 1 deletion mutant strains in sheep after subcutaneous or conjunctival vaccination.Vaccine. 2006 Apr 24;24(17):3461-8. doi: 10.1016/j.vaccine.2006.02.007. Epub 2006 Feb 20. Vaccine. 2006. PMID: 16519974
-
Comparison of subcutaneous and conjunctival routes of Rev 1 vaccination for the prophylaxis of Brucella ovis infection in rams.Res Vet Sci. 1990 Mar;48(2):209-15. Res Vet Sci. 1990. PMID: 2110377
-
Brucella melitensis infection in sheep: present and future.Vet Res. 1998 May-Aug;29(3-4):255-74. Vet Res. 1998. PMID: 9689741 Review.
-
A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats.Prev Vet Med. 1997 Aug;31(3-4):275-83. doi: 10.1016/s0167-5877(96)01110-5. Prev Vet Med. 1997. PMID: 9234451 Review.
Cited by
-
Seroconversion to Brucella spp. and Toxoplasma gondii in Sheep and Goats in Dohuk Province, Iraq and Its Association with Pregnancy Loss.Animals (Basel). 2021 Mar 16;11(3):836. doi: 10.3390/ani11030836. Animals (Basel). 2021. PMID: 33809524 Free PMC article.
-
Identification of the Brucella melitensis vaccine strain Rev.1 in animals and humans in Israel by PCR analysis of the PstI site polymorphism of its omp2 gene.J Clin Microbiol. 2002 Apr;40(4):1475-80. doi: 10.1128/JCM.40.2.1475-1480.2002. J Clin Microbiol. 2002. PMID: 11923376 Free PMC article.
-
Innocuity and immune response to Brucella melitensis Rev.1 vaccine in camels (Camelus dromedarius).Open Vet J. 2014;4(2):96-102. Epub 2014 Oct 25. Open Vet J. 2014. PMID: 26623347 Free PMC article.
-
GFP tagging of Brucella melitensis Rev1 allows the identification of vaccinated sheep.Transbound Emerg Dis. 2019 Jan;66(1):505-516. doi: 10.1111/tbed.13053. Epub 2018 Nov 26. Transbound Emerg Dis. 2019. PMID: 30375177 Free PMC article.
-
Enzyme-linked immunosorbent assay with partially purified cytosoluble 28-kilodalton protein for serological differentiation between Brucella melitensis-infected and B. melitensis Rev.1-vaccinated sheep.Clin Diagn Lab Immunol. 1996 May;3(3):305-8. doi: 10.1128/cdli.3.3.305-308.1996. Clin Diagn Lab Immunol. 1996. PMID: 8705674 Free PMC article.